Skip to main content
. 2019 Jun 6;10:2484. doi: 10.1038/s41467-019-10127-x

Fig. 3.

Fig. 3

PRL3 is expressed on the surface of exosomes from PRL3+ cancer cells. a Representative PRL3 western blot (WB) in purified exosomes from MHCC-LM3 and Hep53.4 liver cancer cells cultured for 24 h in serum-free media. Paxillin served as a negative marker for exosomes, whereas TSG101 is a positive exosomal marker. b Immunofluorescence analysis of MHCC-LM3 cells transiently transfected with green fluorescence protein (GFP) or GFP-PRL3 to reveal plasma membrane enrichment of PRL3. Scale bar, 20 µm. c Representative PRL3 WB in purified exosomes from cells in b after culturing for 24 h in serum-free media. Calnexin served as a negative marker for exosomes. d Purified exosomes from Hep53.4 and Hep53.4-PRL3 were analyzed as in c. e Purified exosomes from cells in c, d were assayed for sensitivity of exosomal PRL3 to proteinase K (Prot. K) digestion in the absence or presence of 1% Triton X-100 detergent. TG101 and Alix are intravesicular exosomal proteins. f Proposed model of the localization of PRL3, TSG101, and Alix in exosomes, based on Prot. K susceptibility observed in e. Source data are provided as a Source Data file